Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark Emberton

Showing results (201-210 of 474) with videos related to

Pageof 48
Sort By:
Plos Medicine|December 21, 2019
Polygenic risk-tailored screening for prostate cancer: A benefit-harm and cost-effectiveness modelling studyTom Callender, Mark Emberton, Steve Morris, et al.
BJU International|October 17, 2013
Influence of baseline variables on changes in International Prostate Symptom Score after combined therapy with dutasteride plus tamsulosin or either monotherapy in patients with benign prostatic hyperplasia and lower urinary tract symptoms: 4-year results of the CombAT studyClaus G Roehrborn, Jack Barkin, Andrea Tubaro, et al.
Medical Image Computing and Computer-Assisted Intervention : MICCAI ... International Conference on Medical Image Computing and Computer-Assisted Intervention|April 30, 2010
MR to ultrasound image registration for guiding prostate biopsy and interventionsYipeng Hu, Hashim Uddin Ahmed, Clare Allen, et al.
BJU International|June 18, 2010
The index lesion and focal therapy: an analysis of the pathological characteristics of prostate cancerSimon R J Bott, Hashim U Ahmed, Richard G Hindley, et al.
European Urology Oncology|May 20, 2023
Prostate Imaging after Focal Ablation (PI-FAB): A Proposal for a Scoring System for Multiparametric MRI of the Prostate After Focal TherapyFrancesco Giganti, Louise Dickinson, Clément Orczyk, et al.
Heliyon|August 21, 2023
A hybrid CNN-RNN approach for survival analysis in a Lung Cancer Screening studyYaozhi Lu, Shahab Aslani, An Zhao, et al.
Oncotarget|March 22, 2018
Systematic identification of functionally relevant risk alleles to stratify aggressive versus indolent prostate cancerSalpie Nowinski, Aida Santaolalla, Ben O'Leary, et al.
Urology|August 16, 2005
Symptom deterioration during treatment and history of AUR are the strongest predictors for AUR and BPH-related surgery in men with LUTS treated with alfuzosin 10 mg once dailyMark Emberton, Mostafa Elhilali, Haim Matzkin, et al.
BJU International|November 22, 2008
Rectal fistulae after salvage high-intensity focused ultrasound for recurrent prostate cancer after combined brachytherapy and external beam radiotherapyHashim U Ahmed, Ayesha Ishaq, Evangelos Zacharakis, et al.
BJU International|November 28, 2006
Visually directed high-intensity focused ultrasound for organ-confined prostate cancer: A proposed standard for the conduct of therapyRowland O Illing, Tom A Leslie, James E Kennedy, et al.
Pageof 48

Showing results (201-210 of 474) with videos related to

Sort By:
Pageof 48
Plos Medicine|December 21, 2019
Polygenic risk-tailored screening for prostate cancer: A benefit-harm and cost-effectiveness modelling studyTom Callender, Mark Emberton, Steve Morris, et al.
BJU International|October 17, 2013
Influence of baseline variables on changes in International Prostate Symptom Score after combined therapy with dutasteride plus tamsulosin or either monotherapy in patients with benign prostatic hyperplasia and lower urinary tract symptoms: 4-year results of the CombAT studyClaus G Roehrborn, Jack Barkin, Andrea Tubaro, et al.
Medical Image Computing and Computer-Assisted Intervention : MICCAI ... International Conference on Medical Image Computing and Computer-Assisted Intervention|April 30, 2010
MR to ultrasound image registration for guiding prostate biopsy and interventionsYipeng Hu, Hashim Uddin Ahmed, Clare Allen, et al.
BJU International|June 18, 2010
The index lesion and focal therapy: an analysis of the pathological characteristics of prostate cancerSimon R J Bott, Hashim U Ahmed, Richard G Hindley, et al.
European Urology Oncology|May 20, 2023
Prostate Imaging after Focal Ablation (PI-FAB): A Proposal for a Scoring System for Multiparametric MRI of the Prostate After Focal TherapyFrancesco Giganti, Louise Dickinson, Clément Orczyk, et al.
Heliyon|August 21, 2023
A hybrid CNN-RNN approach for survival analysis in a Lung Cancer Screening studyYaozhi Lu, Shahab Aslani, An Zhao, et al.
Oncotarget|March 22, 2018
Systematic identification of functionally relevant risk alleles to stratify aggressive versus indolent prostate cancerSalpie Nowinski, Aida Santaolalla, Ben O'Leary, et al.
Urology|August 16, 2005
Symptom deterioration during treatment and history of AUR are the strongest predictors for AUR and BPH-related surgery in men with LUTS treated with alfuzosin 10 mg once dailyMark Emberton, Mostafa Elhilali, Haim Matzkin, et al.
BJU International|November 22, 2008
Rectal fistulae after salvage high-intensity focused ultrasound for recurrent prostate cancer after combined brachytherapy and external beam radiotherapyHashim U Ahmed, Ayesha Ishaq, Evangelos Zacharakis, et al.
BJU International|November 28, 2006
Visually directed high-intensity focused ultrasound for organ-confined prostate cancer: A proposed standard for the conduct of therapyRowland O Illing, Tom A Leslie, James E Kennedy, et al.
Pageof 48